Elekta AB (EKTAY)
7.57
0.00 (0.00%)
USD |
OTCM |
Mar 27, 16:00
Elekta Price to Book Value: 2.937 for March 27, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
March 27, 2024 | 2.937 |
March 26, 2024 | 2.935 |
March 25, 2024 | 2.938 |
March 22, 2024 | 2.922 |
March 21, 2024 | 2.924 |
March 20, 2024 | 2.908 |
March 19, 2024 | 2.933 |
March 18, 2024 | 2.914 |
March 15, 2024 | 2.962 |
March 14, 2024 | 2.916 |
March 13, 2024 | 2.915 |
March 12, 2024 | 2.922 |
March 11, 2024 | 2.872 |
March 08, 2024 | 2.884 |
March 07, 2024 | 2.925 |
March 06, 2024 | 2.845 |
March 05, 2024 | 2.765 |
March 04, 2024 | 2.844 |
March 01, 2024 | 2.918 |
February 29, 2024 | 2.786 |
February 28, 2024 | 2.747 |
February 27, 2024 | 2.723 |
February 26, 2024 | 2.731 |
February 23, 2024 | 2.799 |
February 22, 2024 | 2.813 |
Date | Value |
---|---|
February 21, 2024 | 2.790 |
February 20, 2024 | 2.860 |
February 16, 2024 | 2.871 |
February 15, 2024 | 2.863 |
February 14, 2024 | 2.772 |
February 13, 2024 | 2.716 |
February 12, 2024 | 2.782 |
February 09, 2024 | 2.749 |
February 08, 2024 | 2.710 |
February 07, 2024 | 2.799 |
February 06, 2024 | 2.810 |
February 05, 2024 | 2.749 |
February 02, 2024 | 2.844 |
February 01, 2024 | 2.920 |
January 31, 2024 | 2.939 |
January 30, 2024 | 3.085 |
January 29, 2024 | 3.085 |
January 26, 2024 | 3.085 |
January 25, 2024 | 3.040 |
January 24, 2024 | 3.023 |
January 23, 2024 | 2.986 |
January 22, 2024 | 2.935 |
January 19, 2024 | 2.976 |
January 18, 2024 | 3.031 |
January 17, 2024 | 3.085 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.995
Minimum
Sep 27 2022
6.883
Maximum
Nov 14 2019
4.299
Average
4.387
Median
Oct 08 2021
Price to Book Value Benchmarks
Abliva AB | 1.204 |
Karolinska Development AB | 0.5612 |
Calliditas Therapeutics AB | 17.34 |
Oncopeptides AB | 4.440 |
Olink Holding AB | 5.838 |
Price to Book Value Related Metrics
PE Ratio | 21.31 |
PS Ratio | 1.681 |
PEG Ratio | 0.3257 |
Price to Free Cash Flow | 19.92 |
Price | 7.57 |
Earnings Yield | 4.69% |
Market Cap | 2.892B |
PEGY Ratio | 0.3116 |
Operating PE Ratio | 12.36 |
Normalized PE Ratio | 21.31 |